As evidenced by the detection of virus-like particles in the pulmonary and kidney endothelium of COVID-19 patients, ACE2 is expressed throughout the body’s vasculature, allowing SARS-CoV-2 entry to various organ systems [121]. This evidence concerns the gene ACE2 and COVID-19.